angelman (1)

Upload: tugce-tnc

Post on 04-Apr-2018

235 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 Angelman (1)

    1/56

  • 7/30/2019 Angelman (1)

    2/56

    Angelman Syndrome

    Identified: 1965 by English physician HarryAngelman.Originally named the Happy PuppetSyndrome.First reports in North America were in the1980s.Incidence: 1:15,000-30,000

  • 7/30/2019 Angelman (1)

    3/56

    Physical Characteristics in100% of cases confirmed

    Developmental delaySpeech impairment,none or minimal use of

    words.Movement or balancedisorder: manifested asgait ataxia, or tremulouslimb movements orboth.

  • 7/30/2019 Angelman (1)

    4/56

    Clinical Characteristics

    Any combination of:Frequent laughterFrequent smiling

    Apparent happydemeanorEasily excitableHypermotoric behavior

    Short attention span

    Seizures (this is actually80 90%).

  • 7/30/2019 Angelman (1)

    5/56

    Clinical Characteristics,seen in 20 - 80%

    Flat occiputProtruding TonguePrognathiaWide mouth with widelyspaced teeth.Feeding problems duringinfancyExcessive Appetite

    Frequent droolingHypopigmented skin withlight hair and eye color

    StrabismusAttraction or fascinationwith waterHyperactive lower limbdeep tendon reflexesUplifted, flexed armposition especially duringambulation

    Increased sensitivity to heatSleep disturbance

  • 7/30/2019 Angelman (1)

    6/56

    Angelman Syndrome

    Generally notrecognized until lateinfancy due to absence

    of speech development,and developmentaldelay.

  • 7/30/2019 Angelman (1)

    7/56

  • 7/30/2019 Angelman (1)

    8/56

    Deletion 15 q11-13

    Seen in 65 75% of AS cases.Recurrence risk is less than 1%.

    Tested for with high resolution chromosomeanalysis which can detect up to 70%.Follow up testing with FISH (fluorescent in-

    situ hybridization) is needed due to the fairlyhigh false positive and false negative results of the high resolution chromosome study.

  • 7/30/2019 Angelman (1)

    9/56

    Paternal Uniparental Disomy

    Seen in 3 5% of cases.Less than 1% recurrence rate.

    The patient has 2 paternal copies of chromosome 15.This represents a loss of the genetic

    information from the maternal chromosome15.

  • 7/30/2019 Angelman (1)

    10/56

    IC (imprinting Center) mutation

    7 9% of Angelman cases.The IC activates the maternal 15 q11-13chromosomal material.In absence of the IC, the 15 q11-13 material isnot activated, and Angelman syndrome results.Spontaneous mutations are associated with

  • 7/30/2019 Angelman (1)

    11/56

    UBE3A Mutations

    Seen in 6 20% of cases.If the mutation is spontaneous the recurrencerisk is

  • 7/30/2019 Angelman (1)

    12/56

    UBE3A Mutation

    UBE3A encodes for the protein E6-AP.E6-AP is an enzyme necessary for normalprotein turnover in the cell.In the normal child, only the maternal copy of the UBE3A gene is expressed in the brain.

    The paternal copy is silent.In mice the gene is active in the hippocampus,and cerebellum.

  • 7/30/2019 Angelman (1)

    13/56

    UBE3A Mutation

    Therefore:No UBE3A gene segment

    No E6-AP

    Absence of breakdown of certain proteins within the brain.

  • 7/30/2019 Angelman (1)

    14/56

    Testing

    To test for Angelman Syndrome:Call your local geneticist.

  • 7/30/2019 Angelman (1)

    15/56

    Seizures

    Seen in >80% of individuals with AS.Myoclonic seizures are the most common typewitnessed.Generally the seizures are intractable.

    Ketogenic Diet is the most effective treatment.

  • 7/30/2019 Angelman (1)

    16/56

    Aging

    Increased tendency for fallingWorsening ataxia

    Coincides with the theory that the patient isunable to adequately able to break downcertain proteins in the brain, specifically thecerebellum and hippocampus.

  • 7/30/2019 Angelman (1)

    17/56

  • 7/30/2019 Angelman (1)

    18/56

    Rett Syndrome

    First described by Dr.Andreas Rett in ViennaAustria.

    Worldwide recognitionfollowed a paper by Dr.Bengt Hagberg, andcolleagues in 1983.

  • 7/30/2019 Angelman (1)

    19/56

    Rett Syndrome

    Commonly seen in girlsDescribed in boys, but is usually lethal,causing miscarriage, stillbirth, or early death.

  • 7/30/2019 Angelman (1)

    20/56

    Rett Syndrome

    Occurs in 1:10,000-23,000 live femalebirths.

    75% have a geneticmutation (MECP2) onthe X chromosome(Xq28).Affects people of allethnic backgrounds.

  • 7/30/2019 Angelman (1)

    21/56

    Developmental Characteristics

    Usually show normal or near normaldevelopment until 6 18 months of age.

    Sit independentlyFinger feed at the expected time.Most do not crawl, but tend to bottom scoot, orcombat crawl.

    Many walk at the expected time.

  • 7/30/2019 Angelman (1)

    22/56

  • 7/30/2019 Angelman (1)

    23/56

    Associated manifestations

    Seizures:Non-existant to severe andintractable.Tend to diminish with age.

    Atypical Breathing pattern:Episodes of hyperventilation.Aerophagia.

    Stereotypic handmovements

    Hand wringingHand clappingHand mouthing

  • 7/30/2019 Angelman (1)

    24/56

    Associated Clinical Features

    Autistic Features:Rapid regressionIrritabilityLoss of social skillsDiminished eye contact

    Most of these features tend to decrease somewith age.

  • 7/30/2019 Angelman (1)

    25/56

  • 7/30/2019 Angelman (1)

    26/56

    Genes

    There are approximately 37,000 genes in eachcells nucleus. Each cell type expresses a subset of the geneticmaterial within the nucleus.The subset of genetic material expressed maybe expressed only at specific times in

    development.Each cell needs to turn off about 25,000 itsgenes.

  • 7/30/2019 Angelman (1)

    27/56

    MECP2 Gene

    The MECP2 gene is transcribed and translatedto MeCP2 protein.The MeCP2 protein has 2 functional domains.The 1 st domain binds the MeCP2 protein to theregion of a segment of DNA (at the beginningof genes).The 2 nd domain recruits other proteins toinhibit transcription.

  • 7/30/2019 Angelman (1)

    28/56

  • 7/30/2019 Angelman (1)

    29/56

    Father XY + mother XX

    Son (XY) healthy Daughter ( XX) with

    Rett Syndrome

  • 7/30/2019 Angelman (1)

    30/56

    Father XY + Mother X X

    Son XY (usually

    embryonic lethal)

    Daughter X X Rett

    Syndrome

  • 7/30/2019 Angelman (1)

    31/56

    Recurrence Risk

  • 7/30/2019 Angelman (1)

    32/56

    Long term outcome

    Patients tend to improve after adolesence, butnever return to normal.Death is common in early adulthood due toautonomic dysfunction leading to suddencardiac death.

  • 7/30/2019 Angelman (1)

    33/56

    Tuberous Sclerosis

  • 7/30/2019 Angelman (1)

    34/56

    Background

    First described by Dr. Von Recklinghausen in 1862.Dr. Bourneville in 1880 is usually credited with theinitial description of the disease.

    Vogt (1908) emphasized the association of adenomasebaceum and cerebral scleroses.Triad:

    Adenoma SebaceumMental retardationSeizures

  • 7/30/2019 Angelman (1)

    35/56

  • 7/30/2019 Angelman (1)

    36/56

    Epidemiology

    Frequency: 1:5,800 30,000.No racial, ethnic, or sexual predilection.

    Morbidity and Mortality:Highly variable depending on the severity withwhich an individual is affected.

  • 7/30/2019 Angelman (1)

    37/56

  • 7/30/2019 Angelman (1)

    38/56

  • 7/30/2019 Angelman (1)

    39/56

    Adenoma Sebaceum

  • 7/30/2019 Angelman (1)

    40/56

    Ungual or Periungual fibromas

  • 7/30/2019 Angelman (1)

    41/56

    Hypomelanotic macules > 3

  • 7/30/2019 Angelman (1)

    42/56

    Retinal Harmartomas

  • 7/30/2019 Angelman (1)

    43/56

    Shagreen Patch

  • 7/30/2019 Angelman (1)

    44/56

    Cortical tubers

    http://escuela.med.puc.cl/paginas/Cursos/tercero/AnatomiaPatologica/Imagenes_AP/fotos736-743/738.jpghttp://escuela.med.puc.cl/paginas/Cursos/tercero/AnatomiaPatologica/Imagenes_AP/fotos736-743/739.jpghttp://escuela.med.puc.cl/paginas/Cursos/tercero/AnatomiaPatologica/Imagenes_AP/fotos736-743/738.jpg
  • 7/30/2019 Angelman (1)

    45/56

    Subependymal Nodules

  • 7/30/2019 Angelman (1)

    46/56

    Subependymal Giant CellAstrocytoma

  • 7/30/2019 Angelman (1)

    47/56

  • 7/30/2019 Angelman (1)

    48/56

    Renal Angiomyolipoma

  • 7/30/2019 Angelman (1)

    49/56

    Lymphangioleiomyomatosis

  • 7/30/2019 Angelman (1)

    50/56

    Minor Features

    Multiple randomlydistributed dentalenamel pits.

    Harmartomatous rectalpolypsBone cystsCerebral white matterradial migration lines

    Gingival fibromasNon-renal harmartomasRetinal achromatic

    patchConfetti Skin lesionsMultiple renal cysts

  • 7/30/2019 Angelman (1)

    51/56

  • 7/30/2019 Angelman (1)

    52/56

    Diagnostic Studies

    EEGUseful in evaluation of seizure fociMay be repeated if clinically warranted.

    ECGBaseline should be done to assess for arrhythmiasWolf-Parkinson-White is the most common type of arrhythmia seen in TS.Repeat ECG every 2 3 years until after puberty.

  • 7/30/2019 Angelman (1)

    53/56

    Diagnostic Studies

    EchocardiographyShould be performed in neonatal period if recognized clinically.

    Can be performed in older children to confirm adiagnosis.Repeat echocardiography is not necessary.

  • 7/30/2019 Angelman (1)

    54/56

    Diagnostic Studies

    Renal ultrasoundShould be performed as a baselineRepeat imaging every 5 years before pubertyRepeat imaging every 2 3 years in adults(especially over 30 years)

    CT scan of the chest with contrast:This should be done in women at least once inwomen around the age of 20 30 years to assessfor lymphangioleiomyomatosis.

  • 7/30/2019 Angelman (1)

    55/56

    Treatment

    Generally treatment is symptomaticCognitive outcome is anywhere from normalto profoundly mentally retarded.Seizures can range from none, to easilycontrolled, to intractable.

  • 7/30/2019 Angelman (1)

    56/56

    Questions?